Tin tức & Cập nhật

In percutaneous coronary intervention (PCI) for complex bifurcation lesions, optical coherence tomography (OCT) guidance outdid the angiography-guided approach, findings from the OCTOBER* trial have shown.

Acoramidis has emerged as an important player in the treatment of transthyretin amyloid cardiomyopathy (ATTR-CM), demonstrating encouraging results in the phase III ATTRibute-CM trial.

Alirocumab administered every 2 or 4 weeks (Q2W or Q4W) significantly reduced low-density lipoprotein-cholesterol (LDL-C) levels in paediatric patients with heterozygous familial hypercholesterolaemia (HeFH), according to a study presented at ESC 2023.

Brain disorders – comprising mental illness, neurologic conditions, and stroke – account for over 15 percent of global health loss (how much healthy life is lost due to early death, illness, or ability) in the Global Burden of Disease (GBD) study presented at EAN 2023.

The International Society of Hypertension (ISH) has recently put out a position paper that addresses lifestyle management of hypertension. The paper is endorsed by the World Hypertension League and European Society of Hypertension. [DOI:10.1097/HJH.0000000000003563]

Trong một nghiên cứu được trình bày tại ADA 2023, điều trị với thuốc ức chế đồng vận chuyển kênh natri-glucose 2 (SGLT2i) giúp ngăn chặn sự suy giảm độ lọc cầu thận ước tính (eGFR) và liên quan đến việc giảm nguy cơ biến cố bất lợi về thận ở người trưởng thành mắc bệnh đái tháo đường (ĐTĐ), bất kể tình trạng albumin niệu trước đó.

Catheter ablation boosts outcomes in patients with advanced heart failure (HF) who are being considered for heart transplantation or left ventricular assist device (LVAD) implantation in the CASTLE-HTx trial presented at ESC 2023.